[HTML][HTML] Current treatment for benign prostatic hyperplasia

A Miernik, C Gratzke - Deutsches Ärzteblatt International, 2020 - ncbi.nlm.nih.gov
Current Treatment for Benign Prostatic Hyperplasia - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans

F Fusco, M Creta, C De Nunzio, V Iacovelli… - BMC urology, 2018 - Springer
Background Bladder outlet obstruction is a common urological condition. We aimed to
summarize available evidences about bladder outlet obstruction-induced molecular and …

Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia …

R Vela‐Navarrete, A Alcaraz… - BJU …, 2018 - Wiley Online Library
Objectives To comprehensively evaluate the efficacy and safety of the hexanic extract of
Serenoa repens (HES r, Permixon®; Pierre Fabre Médicament, Castres, France), at a dose …

The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized …

B Chughtai, D Elterman, N Shore, M Gittleman… - Urology, 2021 - Elsevier
Objective To report the results of a multicenter, randomized, controlled trial with a
temporarily implanted nitinol device (iTind; Medi-Tate Ltd, Hadera, Israel) compared to sham …

Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study

Y Sahakyan, A Erman, N Bhojani, B Chughtai… - Prostate Cancer and …, 2023 - nature.com
Background Recently, minimally invasive therapies (MITs), such as water vapor thermal
therapy (WVTT) and prostatic urethral lift (PUL) have become an alternative to surgery or …

Convective thermal therapy: durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to …

CG Roehrborn, SN Gange, MC Gittelman… - The Journal of …, 2017 - auajournals.org
Purpose: We report 2-year outcomes of a multicenter randomized controlled trial plus 1-year
results of a crossover trial after treatment with convective radiofrequency water vapor …

3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction

D Amparore, C Fiori, M Valerio, C Schulman… - Prostate cancer and …, 2021 - nature.com
Background To report the 3-year results of a prospective, single arm, multicenter,
international clinical study with the second generation of the temporary implantable nitinol …

Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

JC Ulchaker, MS Martinson - ClinicoEconomics and Outcomes …, 2017 - Taylor & Francis
Objective To conduct a cost-effectiveness analysis from payers' perspectives of six
treatments for lower urinary tract symptoms (LUTS) associated with benign prostatic …

Three-year treatment outcomes of water vapor thermal therapy compared to doxazosin, finasteride and combination drug therapy in men with benign prostatic …

N Gupta, T Rogers, B Holland, S Helo, D Dynda… - The Journal of …, 2018 - Elsevier
Purpose We evaluated the long-term outcomes of treatment of lower urinary tract symptoms
due to benign prostatic hyperplasia to compare a 1-time water vapor thermal therapy …

Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study

D Campobasso, G Siena, P Chiodini, E Conti… - Prostate Cancer and …, 2023 - nature.com
Abstract Background The Rezum system is one of the latest minimally invasive surgical
treatments for benign prostatic hyperplasia. Methods We retrospectively reviewed all …